SonALAsense is a clinical-stage company developing ALA sonodynamic therapy (SDT) as a first-in-class, non-invasive drug-device combination for the treatment of recurrent glioblastoma multiforme (rGBM) and other deadly cancers. SDT utilizes MRI-guided focused ultrasound (the device) in combination with aminolevulinic acid (a drug) to selectively target and kill tumor cells.
Company Details
- Employees
- 13
- Address
- Oakland, Ca, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://sonalasense.com/
- Keywords
- (HHS).
- HQ
- Oakland, CA
Sonalasense Questions
Sonalasense's website is https://sonalasense.com/
Sonalasense's LinkedIn profile is https://www.linkedin.com/company/sonalasense
Sonalasense has
13 employees.
View email and phone details for 13
employees at Sonalasense.
Sonalasense's industry is
Biotechnology Research
Sonalasense's top competitors are
Omniab, Inc.,
Equator Therapeutics,
Sanius Health,
Alpheus Medical, Inc,
Modality Partnership,
Tempero Bio,
Henlius Usa Inc.,
Via Nova Therapeutics,
Novocure,
Flightpath Biosciences, Inc.
Sonalasense's categories are Biotechnology Research
